These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14624703)

  • 41. Effect of add-on gabapentin on opioid withdrawal symptoms in opium-dependent patients.
    Kheirabadi GR; Ranjkesh M; Maracy MR; Salehi M
    Addiction; 2008 Sep; 103(9):1495-9. PubMed ID: 18783503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals.
    Kahn R; Biswas K; Childress AR; Shoptaw S; Fudala PJ; Gorgon L; Montoya I; Collins J; McSherry F; Li SH; Chiang N; Alathari H; Watson D; Liberto J; Beresford T; Stock C; Wallace C; Gruber V; Elkashef A
    Drug Alcohol Depend; 2009 Jul; 103(1-2):59-64. PubMed ID: 19414226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
    Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF
    J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
    Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of mu-opioid receptors in prepubertal male and female mice.
    Diaz SL; Barros VG; Antonelli MC; Rubio MC; Balerio GN
    Synapse; 2006 Aug; 60(2):132-40. PubMed ID: 16715492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
    Yu E; Miotto K; Akerele E; Montgomery A; Elkashef A; Walsh R; Montoya I; Fischman MW; Collins J; McSherry F; Boardman K; Davies DK; O'Brien CP; Ling W; Kleber H; Herman BH
    Drug Alcohol Depend; 2008 Sep; 97(1-2):158-68. PubMed ID: 18508207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers.
    Haney M; Hart CL; Foltin RW
    Neuropsychopharmacology; 2006 Aug; 31(8):1814-21. PubMed ID: 16407903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J; Seco G; Barranco M; Kyle EM
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial.
    Jones JD; Rajachandran L; Yocca F; Risinger R; De Vivo M; Sabados J; Levin FR; Comer SD
    Am J Drug Alcohol Abuse; 2023 Jan; 49(1):109-122. PubMed ID: 36630319
    [No Abstract]   [Full Text] [Related]  

  • 51. Safety of oral dronabinol during opioid withdrawal in humans.
    Jicha CJ; Lofwall MR; Nuzzo PA; Babalonis S; Elayi SC; Walsh SL
    Drug Alcohol Depend; 2015 Dec; 157():179-83. PubMed ID: 26483357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.
    Moeini M; Omidi A; Sehat M; Banafshe HR
    Eur Addict Res; 2019; 25(1):41-47. PubMed ID: 30630161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
    Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates.
    Gorsane MA; Kebir O; Hache G; Blecha L; Aubin HJ; Reynaud M; Benyamina A
    Subst Abus; 2012; 33(4):336-49. PubMed ID: 22989277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baclofen as a cocaine anti-craving medication: a preliminary clinical study.
    Ling W; Shoptaw S; Majewska D
    Neuropsychopharmacology; 1998 May; 18(5):403-4. PubMed ID: 9536455
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking.
    Cousins MS; Stamat HM; de Wit H
    Nicotine Tob Res; 2001 May; 3(2):123-9. PubMed ID: 11403726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.
    Kamal RM; Schellekens A; De Jong CA; Dijkstra BA
    BMC Psychiatry; 2015 Apr; 15():91. PubMed ID: 25927622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.